This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Helmholtz Zentrum Muenchen—deutsches Forschungzentrum Fuer Gesundheit Un, Other. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Wolfgang Schliebs: Innovator in Medicinal Chemistry
Introduction
Wolfgang Schliebs is a notable inventor based in Herten, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrazolopyridine derivatives. With a total of 2 patents, Schliebs has focused on developing compounds that have therapeutic applications.
Latest Patents
Schliebs' latest patents revolve around pyrazolopyridine derivatives and their use in therapy. These inventions relate to compounds that are useful as medicaments and pharmaceutical compositions. Specifically, they target diseases caused or mediated by parasites of the family Trypanosomatidae, showcasing his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Wolfgang Schliebs has worked with esteemed organizations, including Helmholtz Zentrum München—Deutsches Forschungzentrum für Gesundheit und Umwelt. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Schliebs has collaborated with notable colleagues such as Michael Sattler and Grzegorz Popowicz. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Wolfgang Schliebs stands out as an influential inventor in the realm of medicinal chemistry. His innovative work on pyrazolopyridine derivatives highlights his dedication to developing effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile